GRAIL, Inc. Common Stock (GRAL) is a publicly traded Healthcare sector company. As of July 15, 2026, GRAL trades at $73.17 with a market cap of $3.08B and a P/E ratio of -7.09. GRAL moved +0.07% today. Year to date, GRAL is -14.57%; over the trailing twelve months it is +81.98%. Its 52-week range spans $15.10 to $118.84. Analyst consensus is buy with an average price target of $65.57. Rallies surfaces GRAL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for GRAL, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $73.17 |
| Market Cap | $3.08B |
| P/E Ratio | -7.09 |
| EPS | $-10.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $118.84 |
| 52-Week Low | $15.10 |
| Volume | 49 |
| Avg Volume | 0 |
| Revenue (TTM) | $156.12M |
| Net Income | $-395.32M |
| Gross Margin | 0.00% |
9 analysts cover GRAL: 0 strong buy, 4 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $65.57.